The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Nathan Fowler | ASCO 2018 | Key findings of the phase III RELEVANCE trial in FL

Jun 8, 2018

ASCO Annual Meeting, 1-5 June 2018, Chicago, IL
Nathan Fowler
MD Anderson Cancer Center, Houston, US

Interview topic: Key findings of the phase III RELEVANCE trial in FL

Nathan Fowler | ASCO 2018 | Key findings of the phase III RELEVANCE trial in FL

Your opinion matters

At this year’s virtual ESH Meeting, the Lymphoma Hub Satellite Symposium will evaluate treatment options in patients with R/R DLBCL. What do you think is the most promising emerging therapy in this setting?
4 vote s - 16 hours left ...

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month